![Diasorin Launches LIAISON IQ POC Reader with 10-Minute SARS-CoV-2 Antibody Test - COVID-19 - mobile.Labmedica.com Diasorin Launches LIAISON IQ POC Reader with 10-Minute SARS-CoV-2 Antibody Test - COVID-19 - mobile.Labmedica.com](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2021-04-22/SDD-2734C.jpg)
Diasorin Launches LIAISON IQ POC Reader with 10-Minute SARS-CoV-2 Antibody Test - COVID-19 - mobile.Labmedica.com
![Diasorin scivola dopo il piano al 2025. Akros sospende il giudizio in attesa dell'Investor Day - MilanoFinanza News Diasorin scivola dopo il piano al 2025. Akros sospende il giudizio in attesa dell'Investor Day - MilanoFinanza News](https://www.milanofinanza.it/remote/static.milanofinanza.it/content_upload/img/2021/12/202112170736171385/diasorin-646132.jpg)
Diasorin scivola dopo il piano al 2025. Akros sospende il giudizio in attesa dell'Investor Day - MilanoFinanza News
![DiaSorin S.p.A.: Shareholders Board Members Managers and Company Profile | IT0003492391 | MarketScreener DiaSorin S.p.A.: Shareholders Board Members Managers and Company Profile | IT0003492391 | MarketScreener](https://www.marketscreener.com/static/address/410424.png)
DiaSorin S.p.A.: Shareholders Board Members Managers and Company Profile | IT0003492391 | MarketScreener
![Diasorin, il titolo vola in borsa dopo i conti del primo semestre: utili e ricavi in calo ma sopra le attese - MilanoFinanza News Diasorin, il titolo vola in borsa dopo i conti del primo semestre: utili e ricavi in calo ma sopra le attese - MilanoFinanza News](https://www.milanofinanza.it/remote/static.milanofinanza.it/content_upload/img/2023/07/202307271433549530/Imagoeconomica_1747255-842560.jpg?w=403&h=226&mode=crop&anchor=topcenter&format=jpg&quality=75)